IndraLab

Statements


3 | 1 9

No evidence text available

No evidence text available

No evidence text available

sparser
"Collectively, these results suggest that UCHL3 interacts with FOXM1 to promote its deubiquitination, while concurrently inhibiting the activation of the NLRP3 inflammasome, highlighting a critical molecular mechanism underlying EC protection in the context of diabetes-related complications."

sparser
"UCH-L3-FOXM1 axis could be targeted for the treatment of pancreatic cancer and re-sensitizing gemcitabine resistant cells."

sparser
"In this study, we hypothesized that UCHL3 binds to FOXM1 to promote its deubiquitination and potentially improve DFU outcomes."

sparser
"For instance, the progression of pancreatic cancer is promoted by UCHL3-FOXM1 axis [ xref ]."

sparser
"UCHL3 binds to FOXM1 and promotes FOXM1 deubiquitination while inhibiting NLRP3 inflammasome activation."

sparser
"To further investigate the interaction between UCHL3 and FOXM1, immunoprecipitation assays were performed."

sparser
"UCHL3 interacts with FOXM1 and enhances FOXM1 stabilization as well as reduces FOXM1 turnover via deubiquitination manner, thereby promoting growth, migration, invasion and resistance to gemcitabine in PC [ xref ]."

reach
"Co-immunoprecipitation (co-IP) and in vitro deubiquitination assays were performed to investigate the interactions between UCHL3 and FOXM1."

sparser
"Co-immunoprecipitation (co-IP) and in vitro deubiquitination assays were performed to investigate the interactions between UCHL3 and FOXM1."

sparser
"High UCHL3 expression was positively associated with FOXM1 expression level in pancreatic cancer patient samples."